Organization · Venture Capital
Embryo Ventures
Embryo Ventures is a London-based early-stage venture capital firm that invests in pre-seed and seed startups globally, focusing on HealthTech, DeepTech, and Frontier Innovation.
Overview
What Embryo Ventures does
What Embryo Ventures is
Embryo Ventures is a London-based early-stage venture capital firm that invests in pre-seed and seed startups globally, focusing on HealthTech, DeepTech, and Frontier Innovation.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find Embryo Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Embryo Ventures as a funder
Investment thesis
Embryo Ventures focuses on redefining human experiences through investments in innovative technologies, particularly in health and human experience sectors. Their investment strategy is built on three pillars: Restore, Sustain, and Expand, targeting next-generation clinical technologies, consumer health innovations, and frontier tech that enhances human capabilities.
Focus narrative
Embryo Ventures invests in two primary sectors: Human Health and Human Experience. In Human Health, they back next-generation clinical and consumer technologies aimed at restoring, sustaining, and expanding human health. In Human Experience, they focus on technologies that redefine essential systems of daily life, including connectivity, mobility, care, safety, and built environments. Their investment approach is thematic and opportunistic, spanning various models and categories.
Value beyond capital
Embryo Ventures adds value to its portfolio companies by leveraging its expertise in health and technology sectors, providing strategic guidance, and facilitating connections within the industry. Their thematic investment approach allows them to identify and support innovative solutions that align with their mission to enhance human health and experiences.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Global · Europe · Uk · United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: PLUVO, Thermulon (thermal insulation materials), Cheeky Panda (sustainable bamboo consumer goods), LAKA (insurance for cyclists), BioLumen (biophotonics/health tech), TasteIndex (food intelligence platform), Calla Lily Clinical Care (clinical care product), STAXY, GLADYS, Bridgefy (offline messaging via Bluetooth), OSSTEC (orthopedic implants/bone tech), and IMPLI.
Common questions
What to know about Embryo Ventures
Upseed classifies Embryo Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.